Warning: The NCBI web site requires JavaScript to function. more...

MedGen

National Center for Biotechnology Information

Full Report

Format

Full Report
Summary (Text)
Summary (XML)

Send to:

Choose Destination

File
Clipboard
Collections

MULTIPLE MYELOMA, t(11;14) TYPE, SUSCEPTIBILITY TO

MedGen UID:: 816811
•Concept ID:: C3810481
•: Finding

OMIM®:

Recent clinical studies

Diagnosis

CD20-negative low-grade B cell lymphoma showing immunophenotypic and genotypic features resembling plasma cell myeloma.

Tabata R, Yasumizu R, Tabata C, Kojima M
Pathol Res Pract 2013 Jul;209(7):459-62. Epub 2013 Apr 30 doi: 10.1016/j.prp.2013.04.007. PMID: 23707547

Prognosis

CD20-negative low-grade B cell lymphoma showing immunophenotypic and genotypic features resembling plasma cell myeloma.

Tabata R, Yasumizu R, Tabata C, Kojima M
Pathol Res Pract 2013 Jul;209(7):459-62. Epub 2013 Apr 30 doi: 10.1016/j.prp.2013.04.007. PMID: 23707547

Clinical prediction guides

CD20-negative low-grade B cell lymphoma showing immunophenotypic and genotypic features resembling plasma cell myeloma.

Tabata R, Yasumizu R, Tabata C, Kojima M
Pathol Res Pract 2013 Jul;209(7):459-62. Epub 2013 Apr 30 doi: 10.1016/j.prp.2013.04.007. PMID: 23707547

Supplemental Content

Table of contents

Related information

OMIM
Related records in OMIM
PubMed (OMIM)
Related literature resources in PubMed

Recent activity

Clear Turn Off Turn On

MULTIPLE MYELOMA, t(11;14) TYPE, SUSCEPTIBILITY TO
MULTIPLE MYELOMA, t(11;14) TYPE, SUSCEPTIBILITY TO

MedGen
C3810481[conceptid] (1)
MedGen

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...